- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: SCIO-469 and bortezomib
Total 1192 results
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedPancreatic CancerJapan
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
Giselle ShollerBeat NB Cancer Foundation; Because of Ezra; K C Pharmaceuticals Inc.CompletedNeuroblastoma RecurrentUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
PharmaMarCompletedMultiple MyelomaSpain, France
-
University of CologneJohnson & Johnson Pharmaceutical Research & Development, L.L.C.; German Hodgkin...Terminated
-
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co....RecruitingRelapsed or Refractory Multiple MyelomaChina
-
Henan Cancer HospitalRecruitingMarginal Zone LymphomaChina
-
Samsung Medical CenterActive, not recruitingMultiple MyelomaKorea, Republic of
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCompleted
-
Istituto Scientifico Romagnolo per lo Studio e...Recruiting
-
SanofiCompleted
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.Completed
-
Hackensack Meridian HealthTerminatedMultiple MyelomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
Kite, A Gilead CompanyEnrolling by invitationSolid and Hematological MalignanciesUnited States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
-
Concert PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
Mahidol UniversityMinistry of Health, ThailandUnknown
-
PharmaMarTerminated
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaGermany, Spain, Singapore, United States, Australia
-
Janssen-Ortho Inc., CanadaTerminated
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Janssen Research & Development, LLCActive, not recruiting
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
Peking Union Medical College HospitalXian-Janssen Pharmaceutical Ltd.Active, not recruitingAmyloidosis; SystemicChina
-
Joaquín Martínez López, MD, PhDHospital Infantil Universitario Niño Jesús, Madrid, SpainCompleted
-
University of LouisvilleJames Graham Brown Cancer CenterWithdrawn
-
Massachusetts General HospitalOrtho-McNeil Janssen Scientific Affairs, LLCCompletedSchizoaffective Disorder | Major Depression | Bipolar DepressionUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Washington University School of MedicineSanofiTerminatedMultiple MyelomaUnited States
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
University of FloridaNovartis PharmaceuticalsWithdrawn
-
Sherif Farag, MB, BSHoosier Cancer Research Network; Cephalon, Inc.TerminatedBendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple MyelomaMultiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityNot yet recruitingMultiple Myeloma | Newly Diagnosed | MRD | High Risk
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
PETHEMA FoundationRecruitingRefractory Multiple MyelomaSpain